covid-19
Showing NaN - NaN of 64
COVID-19 Trial in Paris (Lymph node aspiration / Blood sampling)
Recruiting
- COVID-19
- Lymph node aspiration / Blood sampling
-
Paris, FranceGH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 19, 2023
Three Exercise Rehabilitation Strategies on Dyspnea in Patients
Not yet recruiting
- Dyspnea
- COVID-19
-
Argenteuil, France
- +3 more
Jun 6, 2023
Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta
Not yet recruiting
- Vaccine Reaction
- COVID-19
- Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
- VidPrevtyn® Beta vaccine (Sanofi/GSK)
-
Paris, FranceCIC 1417 Cochin-Pasteur
Feb 28, 2023
COVID-19 Trial in Worldwide (Asunercept, Placebo)
Recruiting
- COVID-19
- Asunercept
- Placebo
-
Wien, Austria
- +35 more
Dec 6, 2022
COVID-19 Trial in France (hospitalized children with Covid19)
Recruiting
- COVID-19
- hospitalized children with Covid19
-
Saint Denis, La Réunion, France
- +75 more
Nov 21, 2022
Prevent Hospitalizations for Viral Respiratory Infections in
Not yet recruiting
- Severe Acute Respiratory Infection (SARI)
- +2 more
-
Dijon, France
- +7 more
Oct 17, 2022
COVID-19 Trial in France (DILTIAZEM TEVA 60 mg or )
Not yet recruiting
- COVID-19
- DILTIAZEM TEVA 60 mg or placebo
-
Amiens, France
- +20 more
Sep 30, 2022
Disability Following Hospitalization in People of Working-age
Recruiting
- COVID-19
- Hospitalization
-
Paris, FranceCochin Hospital
Sep 26, 2022
Amiklin Administration During Nosocomial Infections Complicating
Active, not recruiting
- COVID-19
- Nosocomial Infection
-
Paris, France
- +2 more
Aug 19, 2022
HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk
Recruiting
- HIV-1-infection
- COVID-19
- COVID-19
- HIV-1 infection
-
Brussels, Belgium
- +28 more
Aug 2, 2022
COVID-19 Trial in Worldwide (SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, SARS-CoV-2 recombinant protein
Active, not recruiting
- COVID-19
- SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1
- +10 more
-
Birmingham, Alabama
- +71 more
Jul 11, 2022
COVID-19, Vaccine Reaction Trial in Paris (BNT162b2, CoV2 preS dTM adjuvanted vaccine (D614), Sanofi/GSK, CoV2 preS dTM
Active, not recruiting
- COVID-19
- Vaccine Reaction
- BNT162b2
- +2 more
-
Paris, FranceGH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 7, 2022
Vascular Endothelial Glycocalyx and Ophthalmic Injury,
Completed
- COVID-19
- Long COVID
- Ophthalmological examinations
- GlycoCheck
-
Paris, FranceHospital-Foundation Adolphe de Rothschild
Jun 30, 2022
COVID-19 Pandemic on Management of Type 2 DiabeticSample in
Recruiting
- COVID-19
- Diabetes Mellitus, Type 2
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Jun 29, 2022
Geriatric Patients 1 Year After Hospitalization for COVID-19
Not yet recruiting
- COVID-19
-
Paris, FranceService de gériatrie, Hôpital Saint Antoine
Jun 29, 2022
COVID-19 by Delocalized Biology in the Birth Room
Recruiting
- COVID-19
- Labor
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Jun 29, 2022
Healthcare Workers, COVID-19 Trial in Paris
Recruiting
- Healthcare Workers
- COVID-19
-
Paris, FrancePitié-Salpêtrière - Charles Foix, AP-HP
Jun 17, 2022
Hypoxemia, Covid-19 Trial in Paris (Measurement of oxygen saturation)
Withdrawn
- Hypoxemia
- Covid-19
- Measurement of oxygen saturation
-
Paris, FranceService de Pneumologie, Médecine Intensive et Réanimation (SPMIR
May 4, 2022
Immune Response Following COVID-19 in Hemodialysis Patients
Completed
- Dialysis; Complications
- +2 more
-
Paris, FranceAURA Paris
Mar 31, 2022
COVID-19 Trial in Paris (Serology test follow-up)
Active, not recruiting
- COVID-19
- Serology test follow-up
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Mar 30, 2022
One-Year Quality of Life and Functional Prognosis of COVID-19
Active, not recruiting
- COVID-19
- +2 more
- Lung ultrasound
- Muscle ultrasound
-
Beuvry, Hauts-de-France, France
- +2 more
Mar 30, 2022
SARS-CoV-2 Virus Responsible for COVID-19 in France
Recruiting
- SARS (Severe Acute Respiratory Syndrome)
- COVID-19
- Human Biological samples
-
Amiens, France
- +20 more
Mar 8, 2022
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial in Worldwide (SNG001, Placebo)
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVID-19
- SNG001
- Placebo
-
Tucson, Arizona
- +111 more
Mar 2, 2022
COVID-19 Trial in Antwerp, Paris (Two COVID-19 vaccine candidate (TMV-083/V-591) administrations - Low dose, Two COVID-19
Completed
- COVID-19
- Two COVID-19 vaccine candidate (TMV-083/V-591) administrations - Low dose
- +3 more
-
Antwerp, Belgium
- +1 more
Feb 3, 2022